🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.

Experimental Drug Acquiring Traction Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users injecting products of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or prison.

Platform Reaction and Content Removal

Based on the social media company, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately brings up channels with numerous of members, filled with images of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within minutes of entering one group, a seller shared contact information, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Information and Costs

Within these communities, posts show dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it regularly monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to potentially significant health risks”.